Syndax Pharmaceuticals Director Sells $113,716 in Shares
Director Dennis Podlesak sold $113,716 in Syndax Pharmaceuticals common shares.
Related stories
Microsoft Says Consumer Products Services Recovered
Microsoft said its consumer products services had fully recovered, while Microsoft 365 enterprise services were seeing a sustained recovery.
M impact | EQUITY | Nov 14, 2026, 05:17 AM UTC
Microsoft restores consumer product services after outage
Microsoft said its consumer product services have been restored; other services are not included in the update.
M impact | EQUITY | Nov 14, 2026, 05:10 AM UTC
Microsoft Outlook Begins Returning After Global Microsoft 365 Disruption
Microsoft said it was working to restore email access after a global Microsoft 365 disruption. Industry executives warned of risks from dependence on a single technology provider.
M impact | EQUITY | Nov 14, 2026, 04:31 AM UTC
Tesla sells Cybercab to first private customers
Reuters reports Tesla is offering its Cybercab to its first private customers.
M impact | EQUITY | Nov 14, 2026, 04:23 AM UTC
Microsoft says affected services fully recovered
L impact | EQUITY | Nov 14, 2026, 04:14 AM UTC
Eicher Motors Q2 Net Profit Rises 15% but Misses Estimates
Second-quarter consolidated net profit rose 15% year on year to 1,573 crore, below analysts’ estimates. Rising raw-material costs offset gains from strong motorcycle sales.
M impact | EQUITY | Nov 14, 2026, 04:12 AM UTC